Helen Doolittle
Impact in
- Hematology top 10%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
-
- Peptidase Inhibition and Analysis
Papers in
-
- Cell death mechanisms and regulation 1
- Protein Degradation and Inhibitors 1
- Glycosylation and Glycoproteins Research 1
-
- Multiple Myeloma Research and Treatments 2
- Hematopoietic Stem Cell Transplantation 1
- Acute Myeloid Leukemia Research 1
- Co-authors
- Meletios Α. Dimopoulos (2 shared papers)Alistair Reid (2 shared papers)C. Barnes (2 shared papers)Saad Abdalla (2 shared papers)Evangelos Terpos (2 shared papers)Aristeidis Chaidos (2 shared papers)Maria Papaioannou (2 shared papers)Evdoxia Hatjiharissi (2 shared papers)
- Journals
- Blood (2 papers)Oncotarget (1 paper)European Oncology & Haematology (1 paper)
- Partner nations
- United KingdomGreeceSweden
In The Last Decade
Helen Doolittle
4 papers receiving 131 citations
Peers
Comparison fields: 5 of 28
- Hematology 94
- Oncology 41
- Molecular Biology 90
- Immunology 23
- Genetics 8
Countries citing papers authored by Helen Doolittle
This map shows the geographic impact of Helen Doolittle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen Doolittle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen Doolittle more than expected).
Fields of papers citing papers by Helen Doolittle
This network shows the impact of papers produced by Helen Doolittle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen Doolittle. The network helps show where Helen Doolittle may publish in the future.
Co-authors
The 25 scholars most cited alongside Helen Doolittle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 97 | |
| 2 | 2016 | 16 | |
| 3 | 2010 | 12 | |
| 4 | 2012 | 6 |
About Helen Doolittle
Helen Doolittle is a scholar working on Molecular Biology, Hematology, Pathology and Forensic Medicine, Oncology and Genetics, having authored 4 papers that have together received 131 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (2 papers), Cell death mechanisms and regulation (1 paper), Protein Degradation and Inhibitors (1 paper), Hematopoietic Stem Cell Transplantation (1 paper), Glycosylation and Glycoproteins Research (1 paper), Cancer-related Molecular Pathways (1 paper), Acute Myeloid Leukemia Research (1 paper) and Blood disorders and treatments (1 paper). The work is most often cited by research in Hematology (94 citations), Oncology (41 citations), Molecular Biology (90 citations), Immunology (23 citations) and Genetics (8 citations). Helen Doolittle has collaborated with scholars based in United Kingdom, Greece and Sweden. Frequent co-authors include Meletios Α. Dimopoulos, Alistair Reid, C. Barnes, Saad Abdalla, Evangelos Terpos, Aristeidis Chaidos, Maria Papaioannou, Evdoxia Hatjiharissi, Helen Yarranton and Philippa C. May. Their work appears in journals such as Blood, Oncotarget and European Oncology & Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.